Drug Shortage Report for SYNAGIS
| Report ID | 257234 |
| Drug Identification Number | 02438364 |
| Brand name | SYNAGIS |
| Common or Proper name | asdafwe |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PALIVIZUMAB |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | werwer |
| ATC code | J06BD |
| ATC description | |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2021-04-16 |
| Actual start date | |
| Estimated end date | 2022-03-17 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-08-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-08-29 | French | Compare |
| v1 | 2025-08-29 | English | Compare |
Showing 1 to 2 of 2